Evidence map›Paper›PMID 23657508›Full record

ArticleSao Paulo medical journal = Revista paulista de medicina2013

Expression of claudin, paxillin and FRA-1 in non-nodular breast lesions in association with microcalcifications.

José David Kandelman, Angela Flávia Logullo Waitzberg, Jacob Szejnfeld, Ricardo Luiz Smith

Open access · diamondAbstract read
In one paragraph

Article in Sao Paulo medical journal = Revista paulista de medicina, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

José David KandelmanDepartments of Pathology, Radiology and Morphology, Universidade Federal de São Paulo Unifesp, São Paulo, Brazil. kandelman@terra.com.br
Angela Flávia Logullo Waitzberg
Jacob Szejnfeld
Ricardo Luiz Smith
Universidade Federal de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CONTEXT AND

objectiveThe possible role of adhesion molecules in early breast carcinogenesis has been shown in the literature. We aimed to analyze early adhesion imbalances in non-nodular breast lesions and their association with precursor lesions, in order to ascertain whether these alterations exist and contribute towards early carcinogenesis. DESIGN AND

settingRetrospective cross-sectional study based on medical records at a private radiological clinic in São Paulo, Brazil.

methodsWe retrospectively reviewed the medical records of all consecutive women attended between August 2006 and July 2007 who presented mammographic evidence of breast microcalcifications classified as Breast Imaging Reporting and Data System Atlas (BI-RADS) type 4. These women underwent stereotaxic biopsy. Clinical, radiological and pathological data were collected, and immunohistochemical assays searched for claudin, paxillin, FRA-1 and HER-2.

resultsOver this period, 127 patients were evaluated. Previous BI-RADS diagnoses showed that 69 cases were in category 4A, 47 in 4B and 11 in 4C. Morphological assessment showed benign entities in 86.5%. Most of the benign lesions showed preserved claudin expression, associated with paxillin (P < 0.001). Paxillin and HER-2 expressions were correlated. FRA-1 expression was also strongly associated with HER-2 expression (P < 0.001).

conclusionsAlthough already present in smaller amounts, imbalance of adhesion molecules is not necessarily prevalent in non-nodular breast lesions. Since FRA-1 expression reached statistically significant correlations with radiological and morphological diagnoses and HER-2 status, it may have a predictive role in this setting.

Indexed as

Antibodies, MonoclonalBiomarkers, TumorBreastBreast NeoplasmsCalcinosisClaudinsEpidemiologic MethodsErb-b2 Receptor Tyrosine KinasesFemaleFos-Related Antigen 1HumansHyperplasiaPaxillinPrecancerous ConditionsProto-Oncogene Proteins c-fosAntibodies, MonoclonalBiomarkers, TumorClaudinsERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesFos-Related Antigen 1PaxillinProto-Oncogene Proteins c-fos

Identifiers

PMID23657508
PMCPMC10871730
OpenAlexW1873389066

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.